Dublin, April 19, 2023 (GLOBE NEWSWIRE) -- The "Polycystic Ovary Syndrome (PCOS) Treatment: Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.
The global market for Polycystic Ovary Syndrome (PCOS) Treatment estimated at US$2.5 Billion in the year 2022, is projected to reach a revised size of US$3.8 Billion by 2030, growing at a CAGR of 5.5% over the analysis period 2022-2030.
Insulin-Sensitizing Agents, one of the segments analyzed in the report, is projected to record a 5.1% CAGR and reach US$1.4 Billion by the end of the analysis period.
Taking into account the ongoing post pandemic recovery, growth in the Oral Contraceptives segment is readjusted to a revised 6.5% CAGR for the next 8-year period.
The U.S. Market is Estimated at $781.2 Million, While China is Forecast to Grow at 7.2% CAGR
The Polycystic Ovary Syndrome (PCOS) Treatment market in the U.S. is estimated at US$781.2 Million in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$563.7 Million by the year 2030 trailing a CAGR of 7.2% over the analysis period 2022 to 2030.
Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 4% and 5.2% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 4.6% CAGR. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$409.2 Million by the year 2030.
Select Competitors (Total 38 Featured) -
- Abbott Laboratories
- Agile Therapeutics
- Bayer AG
- Eli Lilly And Company
- Ferring Pharmaceuticals, Inc.
- Lupin
- Novartis AG
- Sanofi S.A.
- Teva Pharmaceutical Industries Ltd.
What`s New for 2023?
- Special coverage on Russia-Ukraine war; global inflation; easing of zero-Covid policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.
- Global competitiveness and key competitor percentage market shares
- Market presence across multiple geographies - Strong/Active/Niche/Trivial
- Online interactive peer-to-peer collaborative bespoke updates
- Access to digital archives and Research Platform
- Complimentary updates for one year
Key Attributes:
| Report Attribute | Details |
| No. of Pages | 360 |
| Forecast Period | 2022 - 2030 |
| Estimated Market Value (USD) in 2022 | $2.5 Billion |
| Forecasted Market Value (USD) by 2030 | $3.8 Billion |
| Compound Annual Growth Rate | 5.4% |
| Regions Covered | Global |
Key Topics Covered:
I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
- Impact of Covid-19 and a Looming Global Recession
- Year 2021 in Review and Near-term Outlook
- Prolonged Pandemic, Ukraine-Russia Conflict and Ensuing Economic Disruptions Impact Growth Outlook
- World Economic Growth Projections (Real GDP, Annual % Change) for the Years 2021, 2022 and 2023
- Covid-19 Impact on PCOS Treatment Market
- Competition
- Polycystic Ovary Syndrome (PCOS) Treatment - Global Key Competitors Percentage Market Share in 2022 (E)
- Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
- Polycystic Ovary Syndrome (PCOS) - A Prelude
- Treatment Options Available
- GLOBAL MARKET OVERVIEW AND ANALYSIS
- Global PCOS Treatment Market to Witness Steady Growth
- North America and Europe Dominates, Asia-Pacific to Exhibit Fastest Growth
- Insulin Sensitizing Agents Lead; Metformin - A Widely Prescribed Insulin-sensitizing Agent for PCOS
- Oral Contraceptives to Register Fastest Growth
- Recent Market Activity
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
- Rising Incidence of PCOS and Rising Awareness Drives Market Growth
- Recent Advances in PCOS Management to Spur the Demand for PCOS Drugs
- Growing Prevance of Obesity - A Prime Risk Factor for PCOS Drives Market Growth
- Obesity Prevalence Rate (%) in Select Countries for the Years 2019 and 2030P
- Weight Loss Medications Seek Role in PCOS Treatment
- Dip in Fertility Levels Propels the Demand for PCOS Treatment
- Innovative Therapies Ensure Timely Treatment for Patients Suffering from Polycystic Ovary Syndrome
- Ongoing Research and Development Initiatives Mitigates Risks Pertaining to Infertility and Various Other Pregnancy Related Complications
- Use of Advanced Technologies for Treating Polycystic Ovary Syndrome Witnesses a Surge
- Laparoscopic Ovarian Drilling and other Surgical Procedures Come to the Rescue When Drugs Fail
4. GLOBAL MARKET PERSPECTIVE
III. MARKET ANALYSIS
IV. COMPETITION
For more information about this report visit https://www.researchandmarkets.com/r/z4o1p6
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Attachment
